Osteoporosis / Osteopenia prevalent in chronic pancreatitis

Osteoporosis/Osteopenia prevalent in chronic pancreatitis

(HealthDay)—Sixty-five percent of patients with chronic pancreatitis have osteoporosis or osteopenia, according to a meta-analysis published in the February issue of Clinical Gastroenterology and Hepatology.

Sinead N. Duggan, Ph.D., of Trinity College Dublin, and colleagues performed a systematic review of the literature and meta-analysis to assess the prevalence of and osteopenia in patients with .

The researchers found that 10 studies, involving a total of 513 patients, were eligible for inclusion. The pooled prevalence rate in patients with chronic pancreatitis was 23.4 percent (95 percent confidence interval [CI], 16.6 to 32.0) for osteoporosis and 39.8 percent for osteopenia (95 percent CI, 29.1 to 51.6). Among patients with chronic pancreatitis, the pooled prevalence rate for either osteoporosis or osteopenia was 65 percent (95 percent CI, 54.7 to 74.0).

"We recommend that bone-health assessment should form an integral part of the medical/nutritional work-up of with chronic pancreatitis to prevent and treat osteoporosis and, ultimately, to prevent fracture and its associated morbidity," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Wrist fracture significantly raises risk of hip fracture

Dec 13, 2013

A new study presented today at the IOF Regionals 4th Asia-Pacific Osteoporosis Meeting in Hong Kong supports widespread evidence that individuals who have suffered a fracture are at significantly increased risk of subsequent ...

Stage III/IV melanoma patients at risk for new primaries

Dec 10, 2013

(HealthDay)—Patients with stage III or IV melanoma who have not received treatment with BRAF inhibitors remain at risk for developing new primary melanomas (NPMs), although the incidence rates are lower ...

Recommended for you

Sierra Leone, Liberia brace for new Ebola cases

12 hours ago

Two of the West African nations hardest hit by Ebola were bracing for new caseloads on Monday after trying to outflank the outbreak with a nationwide checkup and a large new clinic.

Reversing the effects of pulmonary fibrosis

12 hours ago

Yale University researchers are studying a potential new treatment that reverses the effects of pulmonary fibrosis, a respiratory disease in which scars develop in the lungs and severely hamper breathing.

User comments